Actelion is a pharmaceuticals and biotechnology company established in December 1997, headquartered in Allschwil near Basel, Switzerland. Actelion focuses on the manufacture of drugs that treat rare diseases and orphan diseases. Some of the drugs it has produced have been used to treat patients with symptoms related to central nervous system disorders, irregular heart conditions, immune system disorders and cancer. One of the focuses of Actelion is treating individuals with pulmonary arterial hypertension (PAH), a heart condition that leaves patients with a short life expectancy (7–9 years) even with treatment. More information...
According to PR-model, actelion.com is ranked 645,827th in multilingual Wikipedia, in particular this website is ranked 111,519th in German Wikipedia.
The website is placed before angela-ascher.de and after graciebarrakaty.com in the BestRef global ranking of the most important sources of Wikipedia.